EWP
BIIB icon

Elevation Wealth Partners’s Biogen BIIB Stock Holding History

Elevation Wealth Partners’s Portfolio BIIB Stock Details BIIB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$50.1K Sell
222
-1
-0.4% -$212 0.01% 390
2026
Q2 		$48.2K Buy
223
+19
+9% +$3.63K 0.01% 311
2026
Q1 		$37.4K Buy
204
+4
+2% +$737 0.01% 282
2025
Q4 		$35.2K Buy
200
+161
+413% +$26.3K 0.01% 284
2025
Q3 		$5.46K Buy
39
+9
+30% +$1.22K ﹤0.01% 464
2025
Q2 		$3.77K Hold
30
– – ﹤0.01% 417
2025
Q1 		$4.11K Hold
30
– – ﹤0.01% 420
2024
Q4 		$4.59K Sell
30
-28
-48% -$4.72K ﹤0.01% 414
2024
Q3 		$11.2K Hold
58
– – ﹤0.01% 349
2024
Q2 		$13.4K Hold
58
– – 0.01% 323
2024
Q1 		$12.5K Buy
58
+28
+93% +$6.56K 0.01% 338
2023
Q4 		$7.71K Hold
30
– – ﹤0.01% 350
2023
Q3 		$7.71K Hold
30
– – 0.01% 256
2023
Q2 		$8.55K Hold
30
– – 0.01% 262
2023
Q1 		$8.34K Buy
+30
New +$8.3K 0.01% 269

Other funds holding BIIB

AIM
Artemis Investment Management Edinburgh, United Kingdom $11.5B AUM 61.77% 1-Year Est. Return
MSV
MN Services Vermogensbeheer The Hague, Netherlands $13.4B AUM 37.34% 1-Year Est. Return
GI
GAMMA Investing Foster City, California $2.96B AUM 34.38% 1-Year Est. Return
SCI
Stableford Capital II Scottsdale, Arizona $288M AUM 21.3% 1-Year Est. Return
FFA
Farther Finance Advisors San Francisco, California $14.2B AUM 18.33% 1-Year Est. Return
TF
Tompkins Financial Ithaca, New York $1.42B AUM 19.14% 1-Year Est. Return
BCM
Boltwood Capital Management Walnut Creek, California $443M AUM 17.72% 1-Year Est. Return
EFG
Everhart Financial Group Dublin, Ohio $1.62B AUM 25.73% 1-Year Est. Return
CI
CX Institutional Auburn, Indiana $3.69B AUM 15.82% 1-Year Est. Return
VCM
Versant Capital Management Phoenix, Arizona $1.17B AUM 28.44% 1-Year Est. Return

Elevation Wealth Partners's BIIB Position: Q3 2026 in Review

Elevation Wealth Partners reduced its Biogen (BIIB) stake by 0.45% in Q3 2026, selling an estimated $212 and leaving 222 shares worth $50.1K. The position accounts for 0.01% of the portfolio, ranked #390.

Elevation Wealth Partners first reported a position in BIIB in Q1 2023 and has held it in 15 quarters since. 32 funds tracked by Wall St. Rank hold BIIB as of Q3 2026.

  • Elevation Wealth Partners held 222 shares of Biogen worth $50.1K as of Q3 2026.
  • Elevation Wealth Partners sold 1 Biogen share in Q3 2026, an estimated $212.
  • Biogen made up 0.01% of Elevation Wealth Partners's portfolio in Q3 2026, its #390 holding.
  • Elevation Wealth Partners first reported a position in Biogen in Q1 2023 and has held it in 15 quarters since.
  • 32 funds tracked by Wall St. Rank held Biogen as of Q3 2026.

Based on Elevation Wealth Partners's 13F filing for Q3 2026, filed 7 Oct 2026.